<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>First Trust Europe Alphadex® Fund — News on 6ix</title>
<link>https://6ix.com/company/first-trust-europe-alphadexr-fund</link>
<description>Latest news and press releases for First Trust Europe Alphadex® Fund on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Fri, 13 Mar 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/first-trust-europe-alphadexr-fund" rel="self" type="application/rss+xml" />
<item>
<title>Firefly Announces Discovery of New Brain Wave Biomarkers For Differential Diagnosis of ADHD</title>
<link>https://6ix.com/company/first-trust-europe-alphadexr-fund/news/firefly-announces-discovery-of-new-brain-wave-biomarkers-for-differential-diagnosis-of-adhd-14</link>
<guid isPermaLink="true">https://6ix.com/company/first-trust-europe-alphadexr-fund/news/firefly-announces-discovery-of-new-brain-wave-biomarkers-for-differential-diagnosis-of-adhd-14</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>Over 22 million Americans are diagnosed with ADHD — yet an objective biological marker for distinguishing between its three distinct subtypes has, to date,</description>
</item>
<item>
<title>KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility</title>
<link>https://6ix.com/company/first-trust-europe-alphadexr-fund/news/koru-medical-systems-announces-eu-mdr-certification-for-the-freedom60r-infusion-pump-with-prefilled-syringe-compatibility-16</link>
<guid isPermaLink="true">https://6ix.com/company/first-trust-europe-alphadexr-fund/news/koru-medical-systems-announces-eu-mdr-certification-for-the-freedom60r-infusion-pump-with-prefilled-syringe-compatibility-16</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>MAHWAH, N.J.--(BUSINESS WIRE)-- KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on</description>
</item>
<item>
<title>Lumentum Thought Leaders to Present at OFC 2026</title>
<link>https://6ix.com/company/first-trust-europe-alphadexr-fund/news/lumentum-thought-leaders-to-present-at-ofc-2026-16</link>
<guid isPermaLink="true">https://6ix.com/company/first-trust-europe-alphadexr-fund/news/lumentum-thought-leaders-to-present-at-ofc-2026-16</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>Michael Hurlston, CEO and Matt Sysak, CTO to participate in Optica Executive Forum SAN JOSE, Calif.--(BUSINESS WIRE)-- Lumentum Holdings Inc. ("Lumentum")</description>
</item>
<item>
<title>POMDOCTOR LIMITED Announces Strategic Upgrade, Focusing on "AI + Medical-Grade Smart Wearables" to Build a New Ecosystem for Full-Cycle Chronic Disease Management</title>
<link>https://6ix.com/company/first-trust-europe-alphadexr-fund/news/pomdoctor-limited-announces-strategic-upgrade-focusing-on-ai-medical-grade-smart-wearables-to-build-a-new-ecosystem-for-full-cycle-chronic-disease-management-7</link>
<guid isPermaLink="true">https://6ix.com/company/first-trust-europe-alphadexr-fund/news/pomdoctor-limited-announces-strategic-upgrade-focusing-on-ai-medical-grade-smart-wearables-to-build-a-new-ecosystem-for-full-cycle-chronic-disease-management-7</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>GUANGZHOU, China, March 13, 2026 /PRNewswire/ -- Pomdoctor Limited ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform</description>
</item>
<item>
<title>CELEBRITY CRUISES IS REDEFINING RIVER TRAVEL WITH THE INDUSTRY'S MOST EXTENSIVE AND EXPERIENTIAL DESTINATION EXPERIENCES</title>
<link>https://6ix.com/company/first-trust-europe-alphadexr-fund/news/celebrity-cruises-is-redefining-river-travel-with-the-industrys-most-extensive-and-experiential-destination-experiences-12</link>
<guid isPermaLink="true">https://6ix.com/company/first-trust-europe-alphadexr-fund/news/celebrity-cruises-is-redefining-river-travel-with-the-industrys-most-extensive-and-experiential-destination-experiences-12</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>Celebrity River Cruises' on-land discovery program offers four curated categories that deliver exclusive and included cultural experiences in cities across</description>
</item>
<item>
<title>Sprinklr Named a Leader in the 2026 Gartner® Magic Quadrant™ for Voice of the Customer Platforms</title>
<link>https://6ix.com/company/first-trust-europe-alphadexr-fund/news/sprinklr-named-a-leader-in-the-2026-gartnerr-magic-quadranttm-for-voice-of-the-customer-platforms-12</link>
<guid isPermaLink="true">https://6ix.com/company/first-trust-europe-alphadexr-fund/news/sprinklr-named-a-leader-in-the-2026-gartnerr-magic-quadranttm-for-voice-of-the-customer-platforms-12</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>NEW YORK--(BUSINESS WIRE)-- Sprinklr (NYSE: CXM), the definitive, AI-native platform for Unified Customer Experience Management (Unified-CXM), today</description>
</item>
<item>
<title>Volatus Aerospace Completes Acquisition of 100% Ownership of Synergy Aviation</title>
<link>https://6ix.com/company/first-trust-europe-alphadexr-fund/news/volatus-aerospace-completes-acquisition-of-100percent-ownership-of-synergy-aviation-18</link>
<guid isPermaLink="true">https://6ix.com/company/first-trust-europe-alphadexr-fund/news/volatus-aerospace-completes-acquisition-of-100percent-ownership-of-synergy-aviation-18</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>MONTRÉAL, March 13, 2026 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV: FLT | OTCQX: TAKOF | FSE: ABB.F) (“Volatus” or the “Company”), a Canadian leader in</description>
</item>
<item>
<title>First Andes Silver Announces New U.S. Stock Symbol</title>
<link>https://6ix.com/company/first-trust-europe-alphadexr-fund/news/first-andes-silver-announces-new-us-stock-symbol-6</link>
<guid isPermaLink="true">https://6ix.com/company/first-trust-europe-alphadexr-fund/news/first-andes-silver-announces-new-us-stock-symbol-6</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>Vancouver, British Columbia--(Newsfile Corp. - March 13, 2026) - FIRST ANDES SILVER LTD. (TSXV: FAS) (OTC: FASLF) (FSE: 9TZ0) ("First Andes" or the "Company")</description>
</item>
<item>
<title>Accertify Introduces Attack State Intelligence to Strengthen Account Protection and Detect Coordinated Login Attacks</title>
<link>https://6ix.com/company/first-trust-europe-alphadexr-fund/news/accertify-introduces-attack-state-intelligence-to-strengthen-account-protection-and-detect-coordinated-login-attacks-8</link>
<guid isPermaLink="true">https://6ix.com/company/first-trust-europe-alphadexr-fund/news/accertify-introduces-attack-state-intelligence-to-strengthen-account-protection-and-detect-coordinated-login-attacks-8</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>New capability helps organizations identify abnormal traffic patterns and account takeover attacks in real time ITASCA, Ill.--(BUSINESS WIRE)-- Accertify, a</description>
</item>
<item>
<title>bioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath® Lung</title>
<link>https://6ix.com/company/first-trust-europe-alphadexr-fund/news/bioaffinity-technologies-announces-record-2025-revenue-and-unit-sales-for-flagship-lung-cancer-diagnostic-cypathr-lung-9</link>
<guid isPermaLink="true">https://6ix.com/company/first-trust-europe-alphadexr-fund/news/bioaffinity-technologies-announces-record-2025-revenue-and-unit-sales-for-flagship-lung-cancer-diagnostic-cypathr-lung-9</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>Laboratory business streamlined in 2025 to focus on profitable diagnostic testing services including the Company’s high-value CyPath® Lung test Number of</description>
</item>
<item>
<title>Kestrel Group Reports Fourth Quarter and Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/first-trust-europe-alphadexr-fund/news/kestrel-group-reports-fourth-quarter-and-full-year-2025-financial-results-14</link>
<guid isPermaLink="true">https://6ix.com/company/first-trust-europe-alphadexr-fund/news/kestrel-group-reports-fourth-quarter-and-full-year-2025-financial-results-14</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>AUSTIN, Texas, March 13, 2026 /PRNewswire/ -- Kestrel Group Ltd (NASDAQ: KG) ("Kestrel" or the "Company") a leading specialty insurance platform that provides</description>
</item>
<item>
<title>Trulieve to Open Medical Cannabis Dispensary in DeLand, Florida</title>
<link>https://6ix.com/company/first-trust-europe-alphadexr-fund/news/trulieve-to-open-medical-cannabis-dispensary-in-deland-florida-13</link>
<guid isPermaLink="true">https://6ix.com/company/first-trust-europe-alphadexr-fund/news/trulieve-to-open-medical-cannabis-dispensary-in-deland-florida-13</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>New Volusia County location will host grand opening celebration Friday, March 20 TALLAHASSEE, Fla., March 13, 2026 /PRNewswire/ -- Trulieve Cannabis Corp.</description>
</item>
<item>
<title>Liberty Live Holdings, Inc. Enters into Exchange Agreements with Certain Holders of its 2.375% Exchangeable Senior Debentures due 2053</title>
<link>https://6ix.com/company/first-trust-europe-alphadexr-fund/news/liberty-live-holdings-inc-enters-into-exchange-agreements-with-certain-holders-of-its-2375percent-exchangeable-senior-debentures-due-2053-12</link>
<guid isPermaLink="true">https://6ix.com/company/first-trust-europe-alphadexr-fund/news/liberty-live-holdings-inc-enters-into-exchange-agreements-with-certain-holders-of-its-2375percent-exchangeable-senior-debentures-due-2053-12</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>ENGLEWOOD, Colo.--(BUSINESS WIRE)-- Liberty Live Holdings, Inc. (“Liberty Live”) (Nasdaq: LLYVA, LLYVK) announced that it has entered into separate,</description>
</item>
<item>
<title>Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/first-trust-europe-alphadexr-fund/news/xenetic-biosciences-inc-reports-full-year-2025-financial-results-23</link>
<guid isPermaLink="true">https://6ix.com/company/first-trust-europe-alphadexr-fund/news/xenetic-biosciences-inc-reports-full-year-2025-financial-results-23</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>Encouraging preclinical and translational data supporting DNase-based approaches to target NETs in difficult-to-treat cancersStrategic focus on</description>
</item>
<item>
<title>ESGold Appoints Veteran Capital Markets Executive Jason Tong as Chief Financial Officer</title>
<link>https://6ix.com/company/first-trust-europe-alphadexr-fund/news/esgold-appoints-veteran-capital-markets-executive-jason-tong-as-chief-financial-officer-9</link>
<guid isPermaLink="true">https://6ix.com/company/first-trust-europe-alphadexr-fund/news/esgold-appoints-veteran-capital-markets-executive-jason-tong-as-chief-financial-officer-9</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>CFO with TSX, TSXV and Nasdaq experience joins leadership team as ESGold strengthens corporate structure ahead of planned gold and silver production in 2026</description>
</item>
<item>
<title>Origin Materials Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call</title>
<link>https://6ix.com/company/first-trust-europe-alphadexr-fund/news/origin-materials-announces-fourth-quarter-and-full-year-2025-earnings-release-date-and-conference-call-17</link>
<guid isPermaLink="true">https://6ix.com/company/first-trust-europe-alphadexr-fund/news/origin-materials-announces-fourth-quarter-and-full-year-2025-earnings-release-date-and-conference-call-17</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>WEST SACRAMENTO, Calif.--(BUSINESS WIRE)-- Origin Materials, Inc. (“Origin,” “Origin Materials,” or “the Company”) (Nasdaq: ORGN, ORGNW), today announced</description>
</item>
<item>
<title>Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)</title>
<link>https://6ix.com/company/first-trust-europe-alphadexr-fund/news/elutia-announces-grants-of-inducement-awards-under-nasdaq-listing-rule-5635c4-4</link>
<guid isPermaLink="true">https://6ix.com/company/first-trust-europe-alphadexr-fund/news/elutia-announces-grants-of-inducement-awards-under-nasdaq-listing-rule-5635c4-4</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>GAITHERSBURG, Md., March 13, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix</description>
</item>
<item>
<title>Xtra-Gold Announces 2026 Normal Course Issuer Bid and Results of 2025 Bid</title>
<link>https://6ix.com/company/first-trust-europe-alphadexr-fund/news/xtra-gold-announces-2026-normal-course-issuer-bid-and-results-of-2025-bid-10</link>
<guid isPermaLink="true">https://6ix.com/company/first-trust-europe-alphadexr-fund/news/xtra-gold-announces-2026-normal-course-issuer-bid-and-results-of-2025-bid-10</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - March 13, 2026) - Xtra-Gold Resources Corp. (TSX: XTG) (OTCQB: XTGRF) ("Xtra- Gold" or the "Company") is pleased to</description>
</item>
<item>
<title>Wolfspeed Appoints Silicon Carbide Industry Veteran Daihui Yu as Regional President, Greater China</title>
<link>https://6ix.com/company/first-trust-europe-alphadexr-fund/news/wolfspeed-appoints-silicon-carbide-industry-veteran-daihui-yu-as-regional-president-greater-china-13</link>
<guid isPermaLink="true">https://6ix.com/company/first-trust-europe-alphadexr-fund/news/wolfspeed-appoints-silicon-carbide-industry-veteran-daihui-yu-as-regional-president-greater-china-13</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>DURHAM, N.C.--(BUSINESS WIRE)-- Wolfspeed is pleased to announce the appointment of Daihui Yu as regional president for Greater China, effective March 16,</description>
</item>
<item>
<title>Escalade Appoints Patrick J. Griffin as Chief Executive Officer and President</title>
<link>https://6ix.com/company/first-trust-europe-alphadexr-fund/news/escalade-appoints-patrick-j-griffin-as-chief-executive-officer-and-president-19</link>
<guid isPermaLink="true">https://6ix.com/company/first-trust-europe-alphadexr-fund/news/escalade-appoints-patrick-j-griffin-as-chief-executive-officer-and-president-19</guid>
<pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
<description>EVANSVILLE, Ind., March 13, 2026 /PRNewswire/ -- The Board of Directors of Escalade, Incorporated, is pleased to announce the appointment of Patrick J.</description>
</item>
</channel>
</rss>